ReviewTuberculosis and respiratory diseases2026
Recent Updates on Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration and Its Clinical Implications.
Review in Tuberculosis and respiratory diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Transbronchial Mediastinal Cryobiopsy-Rising to the Challenge.Respirology (Carlton, Vic.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is the standard minimally invasive method for mediastinal staging in non-small cell lung cancer. As the tumor, node, metastasis (TNM) classification evolves with more refined prognostic stratification of N2 substages, accurate mediastinal evaluation has become increasingly critical. Beyond conventional staging, recent advances have significantly expanded the clinical utility of EBUS-TBNA. This review explores six key areas of development: evidence supporting systematic over targeted mediastinal sampling and the potential to omit confirmatory mediastinoscopy after negative EBUS-TBNA; the role of endoscopic ultrasound in accessing paraesophageal and inferior mediastinal stations; expanded procedural capabilities with third-generation thin scope EBUS; novel tissue acquisition devices, including the 19-gauge needle, mini forceps, and mediastinal cryobiopsy; considerations for tissue adequacy in next-generation sequencing; and image-based adjunctive tools such as elastography and artificial intelligence-driven sonographic analysis. Collectively, these developments underscore the growing role of EBUS-TBNA as a comprehensive diagnostic platform in thoracic oncology, extending its utility from mediastinal staging to peripheral lesion access, molecular profiling, and image-guided decision support.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.